NASDAQ
Arch Therapeutics, Inc. (ARTH) has a eps (basic) of $-2.27 as of Saturday, September 30, 2023. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.
No price data available for this timeframe.